The impact of European embryonic stem cell patent decisions on research strategies

Jan 12, 2015

Authors: A. Mahalatchimy, E. Rial-Sebbag, A.- M. Duguet, F. Taboulet & A. Cambon-Thomsen.

Article in Nature Biotechnology (doi:10.1038/nbt.3105). Reprinted by permission from Macmillan Publishers Ltd: Nature Biotechnology 33,41–43(2015), copyright 2015.

Recent restrictions on the patentability of human embryonic stem cell inventions in Europe necessitate a shift in R&D strategies.

Part of this work is supported by the EUCelLEX project.